-
Some of the thorniest questions that IRBs face are those for which there are no clear-cut answers opinions may vary, arguments on both sides may be compelling, regulatory guidance may be scanty.
-
When the University of Michigan Health System's chief risk officer arrived in 2001, he had already mapped out to institutional leaders an architecture for risk management and medical error disclosure that would dramatically change the system's liability expenses, as well as its approach to patient safety.
-
As medical scientists and engineers in the health care arena pursue advances in drugs and technologies, is now the time to think more critically about these new technologies and how to address future implications for say, the ramifications of genetic screening and designer babies?
-
Most physicians reported in a national survey that they would discuss end-of-life options with a terminally ill patient only when there were no more treatments to offer that patient not when the patient was still feeling well, according to a study published online in CANCER, a peer-reviewed journal of the American Cancer Society, in January.
-
Technological advances in medicine have the capability of helping health care providers to prolong life for patients faced with a terminal illness or injury.
-
Comparative effectiveness research (CER) has the potential to improve outcomes and lower costs, but one key ethical concern is how to best convey to patients that they are participating in research.
-
There is a growing focus on identifying a core set of quality metrics that can be used to improve both palliative and end-of-life care.
-
Data on physicians prescribing is routinely purchased from pharmacies, with physicians identified through information purchased from the American Medical Association.
-
A growing number of clinics around the world are advertising therapeutic applications for stem cell treatments that have not been subjected to well-controlled trials.
-
Health care providers frequently have misconceptions about legal requirements of end-of-life care. By educating providers about how to make decisions when people lose capacity, fewer formal ethics or legal consults will be needed.